Z-L-Ile-CHN2 contains an L-isoleucine-derived amino acid framework bearing a benzyloxycarbonyl (Z, Cbz) protecting group on the amino functionality and a terminal diazomethyl (-CHN2) substituent on the carboxyl-derived side, classifying it as a protected amino acid derivative rather than a free amino acid. The molecule features a stereogenic center consistent with the L designation, a protected α-amino group, and a carboxyl-derived functionality converted into the -CHN2 moiety, providing a chemically distinct diazo handle for subsequent transformations. In synthetic and chemical biology workflows, Z-L-Ile-CHN2 is employed as a diazo-containing amino acid building block for preparing modified amino acid and peptide analogues and for introducing diazo functionality into labeling, conjugation, or structure-activity study materials.
CAT No: CP25178
CAS No:114715-76-3
Chemical Name:N-alpha-Benzyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Z-amino-1-diazo-4-methyl-2-hexanone
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Myotropic activity of allatostatins in tenebrionid beetles
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More